Five years on, first ever tissue-engineered airway transplant remains successful

October 22, 2013

New results published in The Lancet today [Wednesday 23 October] reveal that five years after the first successful transplantation of a tissue-engineered airway (reported in The Lancet in 2008 [1]) the recipient continues to enjoy a good quality of life, and has not experienced any immunological complications or rejection of the implanted airway.

The pioneering operation allowed a 30-year-old Colombian mother of two to receive a new section of tissue engineered trachea (windpipe), after part of her own trachea collapsed due to from tuberculosis. An international team of researchers, led by Professor Paolo Macchiarini from the Karolinska Institutet in Stockholm, Sweden (then at the Hospital Clínic of Barcelona in Spain), implanted a tissue engineered trachea, produced by removing the cells from a human donor trachea, which was then recellularised with cartilage cells (chondrocytes) derived from the patient's own stem cells, and epithelial cells taken from a healthy part of her trachea.

The recipient had no complications from the operation and was discharged from hospital on the 10th postoperative day. As reported in 2008, after 4 months, the graft had a normal appearance and properties, and the patient had no anti-donor antibodies and did not need to take immunosuppressive drugs. However, at the time of publication, researchers cautioned that longer follow-up of the patient would be needed to judge how successful the operation had been.

Now, Professor Macchiarini and colleagues present five year follow-up data from the operation, reporting that the recipient continues to enjoy a good quality of life, including a normal social and working life. Moreover, regular testing of lung function, immunological response to the transplant, and other key indicators reveal that the recipient has retained good and has not experienced any immunological complications.

In addition to regular testing of the implanted trachea's function, the researchers also examined the internal structure of the transplant area using CT scans and bronchoscopy. Six months after surgery, scarring in the area of the graft became apparent, which gradually led to narrowing of part of the airway, resulting in a persistent and worsening cough. This was addressed by implantation of a stent (a scaffold which holds the airway open), and although some scarring remains—and is monitored by regular bronchoscopies—the patient no longer experiences any symptoms.

According to Professor Macchiarini, "These results confirm what we – and many – hoped at the time of the original operation: that tissue engineered transplants are safe and effective in the long term. However, the scarring which occurred in this patient shows that long-term biomechanical stability can be improved, something which is currently under active pre-clinical investigation. The results of a first-in-man active clinical trial will soon provide the definitive evidence that is needed before this stem call based tissue engineering technology can be translated into routine clinical practice."*

In a linked Comment, Professor Alan Russell of the Disruptive Health Technology Institute, at Carnegie Mellon University and the Allegheny Health Network, in Pittsburgh, USA, writes that this is, "the end of the beginning for tissue engineering; the groundwork has been laid for clinical implementation in other specialties….Whole organ tissue engineering is akin to converting a Ford into a Ferrari while driving at top speed. The approach is elegant but fraught with challenges and opportunities for improvement; few medical advances have needed a complete biological understanding before implementation……[but the authors] present compelling evidence that the tracheal graft is now naturalised."

He adds, "Excitement about tracheal regenerative therapy might be muted by realisation that the patient in this study was not restored to full health. Although heroic in complying with the needs of a research study, the patient is suffering from ongoing complications from scarring at the proximal anastamotic site. There is nothing unusual about a tracheal stricture forming at a surgical site and, in fact, this patient had already had such a post-surgical stricture. Rather, the formation of a stricture shows that the remaining challenges for of thin hollow organs such as , oesophagus, intestine, blood vessels, and bladder relate to how neo-tissues are incorporated into existing structures."

Explore further: Sweden hospital in lab-made windpipe transplant

More information: [1] www.thelancet.com/journals/lan … (08)61598-6/fulltext

Research paper: www.thelancet.com/journals/lan … rticle/PIIS0140-6736

Related Stories

Sweden hospital in lab-made windpipe transplant

July 7, 2011
A 36-year-old man who had tracheal cancer has received a new lab-made windpipe seeded with his own stem cells in a procedure in Sweden they call the first successful attempt of its kind, officials said Thursday.

Recipient doing well after first artificial windpipe graft

November 24, 2011
The word's first artificial windpipe transplant has been such a success that a second operation has been carried out and a third is being planned, The Lancet reported on Thursday.

First child to receive stem cell trachea transplant doing well after two years

July 25, 2012
The follow-up of the procedure, carried out in 2010 at Great Ormond Street Hospital (GOSH), shows that the new organ has strengthened and does not appear to have induced any signs of rejection. The 13-year-old boy who received ...

Fat grafting helps patients with scarring problems, reports

September 25, 2013
Millions of people with scars suffer from pain, discomfort, and inability to perform regular activities. Some may have to revert to addicting pain medicine to get rid of their ailments. Now, and with a new methodology, such ...

Recommended for you

New understanding of how muscles work

August 23, 2017
Muscle malfunctions may be as simple as a slight strain after exercise or as serious as heart failure and muscular dystrophy. A new technique developed at McGill now makes it possible to look much more closely at how sarcomeres, ...

Scientists find RNA with special role in nerve healing process

August 22, 2017
Scientists may have identified a new opening to intervene in the process of healing peripheral nerve damage with the discovery that an "anti-sense" RNA (AS-RNA) is expressed when nerves are injured. Their experiments in mice ...

Mouse model of human immune system inadequate for stem cell studies

August 22, 2017
A type of mouse widely used to assess how the human immune system responds to transplanted stem cells does not reflect what is likely to occur in patients, according to a study by researchers at the Stanford University School ...

Researchers offer new targets for drugs against fatty liver disease and liver cancer

August 22, 2017
There may no silver bullet for treating liver cancer or fatty liver disease, but knowing the right targets will help scientists develop the most effective treatments. Researchers in Sweden have just identified a number of ...

Link between cells associated with aging and bone loss

August 21, 2017
Mayo Clinic researchers have reported a causal link between senescent cells - the cells associated with aging and age-related disease - and bone loss in mice. Targeting these cells led to an increase in bone mass and strength. ...

Bio-inspired materials give boost to regenerative medicine

August 18, 2017
What if one day, we could teach our bodies to self-heal like a lizard's tail, and make severe injury or disease no more threatening than a paper cut?

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.